Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced the results of its access to healthcare programs part of the “In reach Africa” program namely Kuza Afya and Tiba Yako in Nairobi and Western Kenya. Kuza Afya is a diabetes and hypertension care programme designed to work with communities and healthcare workers through comprehensive education, screening and care. It was unveiled in January 2019 and rolled out in Bungoma County, Western Kenya until December 2019. During this period, over 70,000 community members were screened for hypertension and 40,000 for diabetes. “Hypertension and diabetes prevalence rates are still very high in Nairobi and Western Kenya regions. However, through Kuza Afya and Tiba Yako we were able to identify the key challenges on the ground being lack of awareness on the diseases and access to healthcare services especially in the grassroots and low income areas. The two programmes helped bridge this gap by equipping m